Medicare Enrolled
Dr. Frederick Tiesenga, MD
Surgery · Elmwood Park, IL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Tiesenga from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Tiesenga?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Tiesenga
Dr. Frederick Tiesenga is a surgery specialist in Elmwood Park, IL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Tiesenga performed 310 Medicare services across 229 unique beneficiaries.
Between the years covered by Open Payments, Dr. Tiesenga received a total of $58,470 from 60 pharmaceutical and/or device companies across 435 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in surgery. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Tiesenga is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 38% volume in IL
$58,470 industry payments
Medicare Practice Summary
Medicare Utilization ↗310
Medicare services
Top 38% in IL for surgery
229
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~16 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
67 | $74 | $281 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
39 | $66 | $274 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
35 | $99 | $366 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
31 | $79 | $353 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
31 | $48 | $176 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
28 | $43 | $155 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
28 | $57 | $245 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $112 | $410 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $97 | $396 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
14 | $133 | $521 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$58,470
Total received (2018-2024)
Avg $8,353/year across 7 years
Top 5% in IL for surgery
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
435
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$27,259 (46.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$23,131 (39.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,080 (12.1%)
Scientific / Research
Research funding and grants
$1,000 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,849
2023
$7,666
2022
$12,913
2021
$10,722
2020
$3,379
2019
$15,582
2018
$6,358
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Kerecis Limited
$443
MIMEDX Group, Inc.
$403
Medtronic, Inc.
$351
TELA Bio, Inc.
$150
Baxter Healthcare
$105
Integra LifeSciences Corporation
$65
Innovation Technologies Inc
$58
Boston Scientific Corporation
$41
Lilly USA, LLC
$38
Pacira Pharmaceuticals Incorporated
$37
Laborie Medical Technologies Corp.
$34
VERTEX PHARMACEUTICALS INCORPORATED
$26
Solventum Corporation
$24
Acera Surgical, Inc.
$23
Aroa Biosurgery Incorporated
$21
W. L. Gore & Associates, Inc.
$16
Echosens North America, Inc.
$15
Top 3 companies account for 64.7% of 2024 payments
All-time payments by company (2018-2024) ›
Applied Medical Resources Corporation
$22,324
Intuitive Surgical, Inc.
$9,799
W. L. Gore & Associates, Inc.
$5,914
Medtronic, Inc.
$2,693
Covidien LP
$2,133
Baxter Healthcare
$2,008
Gyrus ACMI, Inc.
$1,800
Integra LifeSciences Corporation
$1,340
ReShape Lifesciences Inc.
$1,073
Aziyo Biologics, Inc.
$1,000
Davol Inc.
$876
DAVOL INC.
$756
Becton, Dickinson and Company
$639
Apollo Endosurgery US Inc
$538
ACELL, INC.
$522
Kerecis Limited
$443
Teleflex LLC
$416
MIMEDX Group, Inc.
$403
Smith+Nephew, Inc.
$352
Novo Nordisk Inc
$332
Organogenesis Inc.
$290
TELA Bio, Inc.
$273
Lexington Medical, Inc.
$228
Standard Bariatrics, Inc.
$216
Osiris Therapeutics Inc.
$192
Ethicon US, LLC
$189
Innocoll Incorporated
$149
Watermark Medical, Inc.
$144
Endogastric Solutions, Inc
$115
Innovation Technologies Inc
$111
Bard Peripheral Vascular, Inc.
$109
TEI Biosciences Inc
$97
LSI SOLUTIONS INC
$78
Pacira Pharmaceuticals Incorporated
$77
CONMED Corporation
$71
Boston Scientific Corporation
$64
BARD PERIPHERAL VASCULAR, INC.
$58
Transenterix, Inc.
$57
LeMaitre Vascular, Inc.
$56
Heron Therapeutics, Inc.
$56
Smith & Nephew, Inc.
$52
Lilly USA, LLC
$38
Endo Pharmaceuticals Inc.
$38
Laborie Medical Technologies Corp.
$34
Aroa Biosurgery Incorporated
$34
PolyNovo North America LLC
$31
Biom'Up SA
$29
VERTEX PHARMACEUTICALS INCORPORATED
$26
Solventum Corporation
$24
Acera Surgical, Inc.
$23
Avinger Inc.
$22
KCI USA, Inc
$18
Janssen Pharmaceuticals, Inc
$18
Echosens North America, Inc.
$15
Shire North American Group Inc
$13
KCI USA, Inc.
$13
Tactile Systems Technology Inc
$12
Currax Pharmaceuticals LLC
$12
AngioDynamics, Inc.
$12
Monaghan Medical Corporation
$12
Top 3 companies account for 65.1% of all-time payments
Associated products mentioned in payments ›
ACTIV.A.C. · APONVIE · ARES HOME SLEEP TESTING DEVICE · ARISTA AH · ARTEGRAFT VASCULAR GRAFT · Aeon Endostapler & Echelon Flex Powered Stapler · AeroEclipse · AirSeal · Apligraf · BD MAX · BILAYER WOUND MATRIX (BWM) · BIO-A Tissue Reinforcement · CFN ChloraPrep · COLLAGENASE SANTYL · CONTRAVE · Da Vinci Surgical System · ECM Patch · ENDO GIA ULTRA · ESOPHYX · ETHICON · EXPAREL · Endo GIA · Exparel · FLEXITOUCH · FLOSEAL · FibroScan · GATTEX · GELPOINT V-PATH · GORE BIO-A Tissue Reinforcement · GORE ENFORM Preperitoneal Biomaterial · GORE SEAMGUARD Bioabsorbable Staple Line Reinforce · GORE SYNECOR Biomaterial · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · Grafix PL PRIME · GrafixPL · HEMOBLAST Bellows · IRRISEPT · Integra · Irrisept · JARDIANCE · Kerecis Omega3 SurgiClose · LIGASURE · LINX Reflux Management System · LapBand · LigaSure · NASCOBAL · OMNIGRAFT · Optilume BPH Drug Coated Balloon Catheter · Overstitch · OviTex 2S · OviTex Reinforced Bioscaffold With Permanent Polymer (OviTex) · PANTHERIS · PATCH · PERCLOT · PERI-STRIPS DRY · PHASIX · PLEDGET AND INTRACARDIAC · PROGEL · Phasix · Phasix Mesh · Pouch · Puraply · RUNNING DEVICE RD180 · Restrata Wound Matrix · SEAMGUARD · SEAMGUARD Bioabsorbable Staple Line Reinforcement · SEAMGUARD Staple Line Reinforcement · SIGNIA · SONICISION · STAPLER · STAPLING · SURGICEL Family of Absorbable Hemostats · SURGIMEND · SYNECOR Biomaterial · Santyl · Saxenda · Senhance Surgical Robotics System · Signia · Sonicision · SpyGlass Discover · Stravix · TISSEEL · TITAN SGS STANDARD GASTRIC STAPLER · TYKE · Titan SGS Standard Gastric Stapler · ULTRAFLEX · V.A.C. DERMATAC · VAC ULTA · VENACURE 1470 PRO · VISTASEAL · VOYANT · Valleylab · Valleylab FT10 · Voyant electrosurgical generator · Voyant fine fusion device · Voyant open fusion device · Wegovy · XARACOLL · XARELTO · ZEPBOUND · iDrive Ultra
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (47%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for surgery in IL.
Geographic Context
Surgerists within 10 mi
955
Per 100K population
18.4
County median income
$81,797
Nearest hospital
SHRINERS HOSPITAL FOR CHILDREN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Tiesenga is a clinical cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 5% of IL peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Tiesenga experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Tiesenga performed 67 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Tiesenga receive payments from pharmaceutical companies?
Yes. Dr. Tiesenga received a total of $58,470 from 60 companies across 435 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Tiesenga's costs compare to other surgerists in Elmwood Park?
Dr. Tiesenga's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Tiesenga) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Surgerists in Elmwood Park
Browse surgerists in Elmwood Park ranked by procedure volume and transparency data.
Highest volume
Top Surgerists in IL
Surgerists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Surgerists in IL
Which IL surgerists receive the most from drug and device companies.
By company
Applied Medical Resources Corporation Payments to Doctors
See all physicians who received payments from Applied Medical Resources Corporation.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
W. L. Gore & Associates, Inc. Payments to Doctors
See all physicians who received payments from W. L. Gore & Associates, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology